Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Re-attendance in supplemental breast MRI screening rounds of the DENSE trial for women with extremely dense breasts.
Veenhuizen SGA, van Grinsven SEL, Laseur IL, Bakker MF, Monninkhof EM, de Lange SV, Pijnappel RM, Mann RM, Lobbes MBI, Duvivier KM, de Jong MDF, Loo CE, Karssemeijer N, van Diest PJ, Veldhuis WB, van Gils CH; DENSE Trial Study Group. Veenhuizen SGA, et al. Among authors: monninkhof em. Eur Radiol. 2024 Oct;34(10):6334-6347. doi: 10.1007/s00330-024-10685-9. Epub 2024 Apr 19. Eur Radiol. 2024. PMID: 38639912 Free PMC article. Clinical Trial.
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, Emaus MJ, Loo CE, Bisschops RHC, Lobbes MBI, de Jong MDF, Duvivier KM, Veltman J, Karssemeijer N, de Koning HJ, van Diest PJ, Mali WPTM, van den Bosch MAAJ, Veldhuis WB, van Gils CH; DENSE Trial Study Group. Bakker MF, et al. Among authors: monninkhof em. N Engl J Med. 2019 Nov 28;381(22):2091-2102. doi: 10.1056/NEJMoa1903986. N Engl J Med. 2019. PMID: 31774954 Clinical Trial.
Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trial.
Menne Guricová K, Pos FJ, Schoots IG, Vogel WV, Kerkmeijer LGW, Monninkhof EM, de Boer JCJ, van der Voort van Zyp JRN, Kunze-Busch M, Smeenk RJ, Draulans C, Haustermans K, van Houdt PJ, van der Heide UA. Menne Guricová K, et al. Among authors: monninkhof em. Radiother Oncol. 2024 Sep 13;201:110535. doi: 10.1016/j.radonc.2024.110535. Online ahead of print. Radiother Oncol. 2024. PMID: 39278316
Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial.
Draulans C, Haustermans K, Pos FJ, van der Heide UA, De Cock L, van der Voort van Zyp J, De Boer H, Smeenk RJ, Kunze-Busch M, Monninkhof EM, De Roover R, Isebaert S, Kerkmeijer LGW. Draulans C, et al. Among authors: monninkhof em. Radiother Oncol. 2024 Oct 2;201:110568. doi: 10.1016/j.radonc.2024.110568. Online ahead of print. Radiother Oncol. 2024. PMID: 39362607
Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate Cancer.
Menne Guricová K, Groen V, Pos F, Monninkhof E, Elias SG, Haustermans K, Smeenk RJ, van der Voort van Zyp J, Draulans C, Isebaert S, van Houdt PJ, Kerkmeijer LGW, van der Heide UA. Menne Guricová K, et al. Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):66-73. doi: 10.1016/j.ijrobp.2023.07.044. Epub 2023 Sep 18. Int J Radiat Oncol Biol Phys. 2024. PMID: 37725026
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial.
Hiensch AE, Depenbusch J, Schmidt ME, Monninkhof EM, Pelaez M, Clauss D, Gunasekara N, Zimmer P, Belloso J, Trevaskis M, Rundqvist H, Wiskemann J, Müller J, Sweegers MG, Fremd C, Altena R, Gorecki M, Bijlsma R, van Leeuwen-Snoeks L, Ten Bokkel Huinink D, Sonke G, Lahuerta A, Mann GB, Francis PA, Richardson G, Malter W, van der Wall E, Aaronson NK, Senkus E, Urruticoechea A, Zopf EM, Bloch W, Stuiver MM, Wengstrom Y, Steindorf K, May AM. Hiensch AE, et al. Among authors: monninkhof em. Nat Med. 2024 Oct;30(10):2957-2966. doi: 10.1038/s41591-024-03143-y. Epub 2024 Jul 25. Nat Med. 2024. PMID: 39054374 Free PMC article. Clinical Trial.
Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies.
Fontvieille E, Viallon V, Recalde M, Cordova R, Jansana A, Peruchet-Noray L, Lennon H, Heath AK, Aune D, Christakoudi S, Katzke V, Kaaks R, Inan-Eroglu E, Schulze MB, Mellemkjær L, Tjønneland A, Overvad K, Farràs M, Petrova D, Amiano P, Chirlaque MD, Moreno-Iribas C, Tin Tin S, Masala G, Sieri S, Ricceri F, Panico S, May AM, Monninkhof EM, Weiderpass E, Gunter MJ, Ferrari P, Freisling H. Fontvieille E, et al. Among authors: monninkhof em. BMC Med. 2023 Nov 23;21(1):418. doi: 10.1186/s12916-023-03114-z. BMC Med. 2023. PMID: 37993940 Free PMC article.
Effect of Physical Exercise on MRI-Assessed Brain Perfusion in Chemotherapy-Treated Breast Cancer Patients: A Randomized Controlled Trial.
Koevoets EW, Petr J, Monninkhof EM, Geerlings MI, Witlox L, van der Wall E, Stuiver MM, Sonke GS, Velthuis MJ, Jobsen JJ, van der Palen J, Mutsaerts HJMM, de Ruiter MB, May AM, Schagen SB; PAM Study Group. Koevoets EW, et al. Among authors: monninkhof em. J Magn Reson Imaging. 2024 May;59(5):1667-1680. doi: 10.1002/jmri.28967. Epub 2023 Oct 6. J Magn Reson Imaging. 2024. PMID: 37801027 Clinical Trial.
A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
Christakoudi S, Tsilidis KK, Dossus L, Rinaldi S, Weiderpass E, Antoniussen CS, Dahm CC, Tjønneland A, Mellemkjær L, Katzke V, Kaaks R, Schulze MB, Masala G, Grioni S, Panico S, Tumino R, Sacerdote C, May AM, Monninkhof EM, Quirós JR, Bonet C, Sánchez MJ, Amiano P, Chirlaque MD, Guevara M, Rosendahl AH, Stocks T, Perez-Cornago A, Tin Tin S, Heath AK, Aglago EK, Peruchet-Noray L, Freisling H, Riboli E. Christakoudi S, et al. Among authors: monninkhof em. BMC Cancer. 2023 Jun 19;23(1):562. doi: 10.1186/s12885-023-11056-1. BMC Cancer. 2023. PMID: 37337133 Free PMC article.
Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis.
Hiensch AE, Beckhaus J, Witlox L, Monninkhof EM, Schagen SB, van Vulpen JK, Sweegers MG, Newton RU, Aaronson NK, Galvão DA, Steindorf K, Stuiver MM, Mesters I, Knoop H, Goedendorp MM, Bohus M, Thorsen L, Schulz KH, Schmidt ME, Ulrich CM, Sonke GS, van Harten WH, Winters-Stone KM, Velthuis MJ, Taaffe DR, van Mechelen W, Kersten MJ, Nollet F, Wiskemann J, Buffart LM, May AM. Hiensch AE, et al. Among authors: monninkhof em. J Cancer Surviv. 2024 Oct;18(5):1492-1503. doi: 10.1007/s11764-023-01392-3. Epub 2023 May 9. J Cancer Surviv. 2024. PMID: 37160571 Free PMC article.
129 results